A vs TXMD · P/E 29, rev $1.88B vs rev $1.8M
Agilent Technologies Inc (A) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
A currently screens at market cap $33.70B and trailing P/E 29.2. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the A and TXMD stock pages for the full models.
Not investment advice.